164 related articles for article (PubMed ID: 8407315)
1. Sedimentation rate and serum thymidine kinase activity: prognostic factors in squamous cell head and neck cancer.
Fontana X; Dassonville O; Néri J; Vallicioni J; Santini J; Milano G; Combon P; Lapalus F; Demard F
Head Neck; 1993; 15(5):425-32. PubMed ID: 8407315
[TBL] [Abstract][Full Text] [Related]
2. The clinical value of serum squamous cell carcinoma antigens 1 and 2 in head and neck squamous cell carcinoma.
Yasumatsu R; Nakano T; Hashimoto K; Kogo R; Wakasaki T; Nakagawa T
Auris Nasus Larynx; 2019 Feb; 46(1):135-140. PubMed ID: 30078551
[TBL] [Abstract][Full Text] [Related]
3. Conventional tumor markers are prognostic indicators in patients with head and neck squamous cell carcinoma.
Kimura Y; Fujieda S; Takabayashi T; Tanaka T; Sugimoto C; Saito H
Cancer Lett; 2000 Jul; 155(2):163-8. PubMed ID: 10822131
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of serum squamous cell carcinoma antigen in patients with head and neck cancer.
Imai R; Takenaka Y; Yasui T; Nakahara S; Yamamoto Y; Hanamoto A; Takemoto N; Fukusumi T; Cho H; Yamamoto M; Inohara H
Acta Otolaryngol; 2015 Mar; 135(3):295-301. PubMed ID: 25622661
[TBL] [Abstract][Full Text] [Related]
5. Correlation between Serum Squamous Cell Carcinoma Antigen Level and Tumor Volume in Head and Neck Cancer.
Jantharapattana K; Kotamnivates T; Hirunpat S; Jarumanokul R
ORL J Otorhinolaryngol Relat Spec; 2018; 80(5-6):284-289. PubMed ID: 30092593
[TBL] [Abstract][Full Text] [Related]
6. Squamous cell carcinoma antigen as a prognostic marker and its correlation with clinicopathological features in head and neck squamous cell carcinoma: Systematic review and meta-analysis.
Travassos DC; Fernandes D; Massucato EMS; Navarro CM; Bufalino A
J Oral Pathol Med; 2018 Jan; 47(1):3-10. PubMed ID: 28600896
[TBL] [Abstract][Full Text] [Related]
7. Study of cyfra 21-1, a tumor marker, in head and neck squamous cell carcinoma.
Céruse P; Rabilloud M; Charrié A; Dubreuil C; Disant F
Ann Otol Rhinol Laryngol; 2005 Oct; 114(10):768-76. PubMed ID: 16285267
[TBL] [Abstract][Full Text] [Related]
8. Interactions between clinical factors, p16, and cyclin-D1 expression and survival outcomes in oropharyngeal and hypopharyngeal squamous cell carcinoma.
Ang SH; Haaland B; Acharyya S; Thu MM; Krisna SS; Hwang SG; Tan PH; Ng QS; Tan DS; Tai WM; Tan EH; Lim WT; Ang MK
Head Neck; 2015 Nov; 37(11):1650-9. PubMed ID: 24953865
[TBL] [Abstract][Full Text] [Related]
9. Squamous cell carcinoma antigen in serum for monitoring of head and neck and uterine cervical squamous cell carcinomas after radiotherapy.
Shirato H; Ichimura W; Wakushima H; Nishioka T; Suzuki K
Acta Oncol; 1993; 32(6):663-6. PubMed ID: 8260185
[TBL] [Abstract][Full Text] [Related]
10. The Diagnostic and Prognostic Value of Tumor Markers (CEA, SCC, CYFRA 21-1, TPS) in Head and Neck Cancer Patients.
Barak V; Meirovitz A; Leibovici V; Rachmut J; Peretz T; Eliashar R; Gross M
Anticancer Res; 2015 Oct; 35(10):5519-24. PubMed ID: 26408719
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of SCC antigen in the serum of patients with head and neck cancer.
Molina R; Torres MD; Moragas M; Perez-Villa J; Filella X; Jo J; Farrus B; Giménez N; Traserra J; Ballesta AM
Tumour Biol; 1996; 17(2):81-9. PubMed ID: 8658017
[TBL] [Abstract][Full Text] [Related]
12. Tumor markers in the diagnosis and follow-up of head and neck cancer: role of CEA, CA 19-9, SCC, TK, and dTTPase.
Walther EK; Dahlmann N; Gorgulla HT
Head Neck; 1993; 15(3):230-5. PubMed ID: 8387981
[TBL] [Abstract][Full Text] [Related]
13. Concentration of free hCGbeta subunit in serum as a prognostic marker for squamous-cell carcinoma of the oral cavity and oropharynx.
Hedström J; Grenman R; Ramsay H; Finne P; Lundin J; Haglund C; Alfthan H; Stenman UH
Int J Cancer; 1999 Oct; 84(5):525-8. PubMed ID: 10502732
[TBL] [Abstract][Full Text] [Related]
14. Analysis of preoperative serum levels of MMP1, -2, and -9 in patients with site-specific head and neck squamous cell cancer.
Kalfert D; Ludvikova M; Topolcan O; Windrichova J; Malirova E; Pesta M; Celakovsky P
Anticancer Res; 2014 Dec; 34(12):7431-41. PubMed ID: 25503184
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Cyfra 21-1 and SCC assays in head and neck tumours.
Banal A; Hacene K; Berthelot-Ruff E; Mahé E; Fontana X; Pichon MF
Tumour Biol; 2001; 22(1):27-35. PubMed ID: 11054024
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor beta1 (TGFbeta1) expression in head and neck squamous cell carcinoma patients as related to prognosis.
Logullo AF; Nonogaki S; Miguel RE; Kowalski LP; Nishimoto IN; Pasini FS; Federico MH; Brentani RR; Brentani MM
J Oral Pathol Med; 2003 Mar; 32(3):139-45. PubMed ID: 12581383
[TBL] [Abstract][Full Text] [Related]
17. The prognostic significance of pre- and posttreatment SCC levels in patients with squamous cell carcinoma of the cervix treated by radiotherapy.
Hong JH; Tsai CS; Chang JT; Wang CC; Lai CH; Lee SP; Tseng CJ; Chang TC; Tang SG
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):823-30. PubMed ID: 9652844
[TBL] [Abstract][Full Text] [Related]
18. Serum SCC-Ag in head and neck squamous cell carcinoma.
Palermo F; Carniato A; Fede A; Boccaletto F; Marchiori C
Int J Biol Markers; 1990; 5(3):118-20. PubMed ID: 2286775
[TBL] [Abstract][Full Text] [Related]
19. The influence of reactivation of the telomerase in tumour tissue on the prognosis of squamous cell carcinomas in the head and neck.
Koscielny S; Eggeling Fv; Dahse R; Fiedler W
J Oral Pathol Med; 2004 Oct; 33(9):538-42. PubMed ID: 15357674
[TBL] [Abstract][Full Text] [Related]
20. Relation between the level of lymph node metastasis and survival in locally advanced head and neck squamous cell carcinoma.
Xing Y; Zhang J; Lin H; Gold KA; Sturgis EM; Garden AS; Lee JJ; William WN
Cancer; 2016 Feb; 122(4):534-45. PubMed ID: 26554754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
